Purchase Order 75N90020P00540
Award Date 7/2/20
Potential Completion Date 7/10/20
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27712, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The NIH Clinical Center awarded a purchase order to Biomerieux Inc. for $14,448.00 on April 16, 2018, with completion scheduled for April 15, 2019. Performance occurs in Durham, North Carolina. The order is firm fixed price with no set-aside designation. Biomerieux, operating as Vitek Systems, Inc., supplies in vitro diagnostic equipment, reagents, and test kits for clinical laboratory applications, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms used across federal...
- The NIH Clinical Center issued a $15,188.00 delivery order to Biomerieux Inc. on September 6, 2019, under the GSA Federal Supply Schedule (FSS-66) for Scientific Equipment and Services. Place of performance is Durham, NC. The order is firm fixed price with no set-aside. Ultimate completion date is September 6, 2019. Biomerieux operates through its Vitek Systems, Inc. division and supplies diagnostic equipment and reagents including VITEK microorganism identification systems, BioFire test kits,...
- Biomerieux Inc. was awarded a purchase order valued at $24,995.61 by the NIH Clinical Center on July 9, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price contract represents a direct procurement with no set-aside designation. The NIH Clinical Center, a component of the National Institutes of Health, procures specialized diagnostic and laboratory solutions to support its clinical research and patient care missions. Biomerieux, operating under the trade name Vitek...
- <p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on March 30, 2018, for $14,285.84 with a firm fixed-price structure and an ultimate completion date of April 29, 2018. Place of performance is Bethesda, Maryland. The order procures in vitro diagnostic equipment, reagents, or test kits—Biomerieux's core offerings in microorganism identification and clinical laboratory testing. No set-aside was applied to this acquisition.</p>
- The NIH Clinical Center issued a purchase order to Biomerieux Inc. on July 20, 2018, with a ceiling value of $263,153.78 for firm fixed-price diagnostic supplies and equipment. The order was administratively de-obligated on a de-obligation notice dated July 20, 2018, to close unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 close of the period of availability. Place of performance is Bethesda, Maryland. The...
- This is a $19,631.60 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics and microbiological testing solutions. The contract has an ultimate completion date of September 30, 2025 and is not set aside. Biomerieux Inc., doing business as Vitek Systems, Inc., will provide specialized diagnostic platforms, reagents, test kits, and clinical laboratory technologies to support the NIH Clinical...
- Biomerieux Inc., operating as Vitek Systems, Inc., was awarded a firm fixed-price purchase order valued at $135,341.41 by the National Institutes of Health Clinical Center for diagnostic equipment and supplies. The contract, awarded on May 31, 2019, with an ultimate completion date of May 31, 2022, represents the procurement of in vitro diagnostic solutions from this specialized supplier of microbiological testing platforms. The award carries no set-aside designation, reflecting Biomerieux's...
- <p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. for $17,310.26 on December 1, 2017, with a ceiling value of $17,310.26 under firm fixed-price terms. The order is for diagnostic equipment, reagents, and test kits to support microbiological testing and clinical laboratory operations. Performance occurs at Bethesda, Maryland. The order is scheduled for completion by December 8, 2017.</p>
- <p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on May 29, 2018, with a ceiling value of $9,544.74. The order carries firm fixed-price terms and no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is June 8, 2018.</p>
- <p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on April 16, 2018, for $9,166.20 with a firm fixed price structure and no set-aside designation. Place of performance is Bethesda, Maryland. The order ceiling is due for ultimate completion on April 17, 2018. The source does not specify the detailed scope of supplies or services being procured under this purchase order.</p>
The National Institutes of Health Clinical Center issued a purchase order to Biomerieux Inc. on July 2, 2020, with a ceiling value of $20,986.60 and an ultimate completion date of July 10, 2020. The order carries firm fixed-price pricing and no set-aside designation. Performance takes place in Durham, North Carolina. The purchase order procures diagnostic equipment, reagents, or test kits from Biomerieux's portfolio of microbiological testing and in vitro diagnostic solutions, including its proprietary VITEK, BioFire, and VIDAS platforms and associated consumables.
Generated 6/4/26, 12:19 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.0k | 7/1/20 |